Dania Therapeutics ApS — Credit Rating and Financial Key Figures

Dania Therapeutics ApS (CVR number: 42523925) is a company from GENTOFTE. The company recorded a gross profit of -9191.4 kDKK in 2023. The operating profit was -10.4 mDKK, while net earnings were -8722 kDKK. The profitability of the company measured by Return on Assets (ROA) was -107.8 %, which can be considered poor and Return on Equity (ROE) was -97.5 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -7.5 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Dania Therapeutics ApS's liquidity measured by quick ratio was 22.2 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.